Who Exports Amoxicillin from India — 633 Suppliers Behind a $610.1M Market

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs), including Amoxicillin. The city hosts numerous pharmaceutical companies specializing in API manufacturing, contributing significantly to India's export capacity. For instance, Aurobindo Pharma Limited, headquartered in Hyderabad, is a major exporter of Amoxicillin, accounting for $103.1 million (16.9%) of total exports. The concentration of API manufacturers in Hyderabad ensures a robust supply chain for bulk drug production.

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies in this region excel in producing finished dosage forms of antibiotics like Amoxicillin. Alembic Pharmaceuticals, based in Vadodara, is a notable player in this cluster, contributing to the formulation and export of Amoxicillin products. The region's emphasis on formulations complements the API production in other clusters, facilitating a seamless transition from raw materials to finished products.

The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products, including Amoxicillin. This region's well-developed infrastructure and proximity to major ports like Nhava Sheva enable efficient export operations. Companies such as Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage this strategic location to distribute their products globally. Sun Pharma is among the top exporters of Amoxicillin, with exports totaling $17.7 million (2.9%). The region's logistical advantages enhance India's position in the global pharmaceutical supply chain.

The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives and supportive government policies. This area attracts numerous pharmaceutical companies specializing in the production of various drugs, including Amoxicillin. The tax benefits and cost-effective manufacturing environment make Baddi-Nalagarh an attractive destination for pharmaceutical production.

• Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.

• Leverage API and Formulation Synergies: Utilize the strengths of Hyderabad for API sourcing and Ahmedabad-Vadodara for formulations to optimize the supply chain.

• Optimize Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to ensure timely and efficient distribution of Amoxicillin products.

• Monitor Regulatory Compliance: Stay updated with guidelines from regulatory bodies such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to ensure compliance in sourcing and exporting activities.

By strategically engaging with these pharmaceutical clusters and adhering to regulatory standards, companies can enhance their sourcing strategies for Amoxicillin, ensuring a resilient and efficient supply chain.